Nearly a year has gone by since several Chilean lawmakers asked the government to make it possible to issue compulsory licenses for prescription drugs, but no action was taken. Now, more than two dozen advocacy groups from around the world are pressing the health ministry to proceed.

Last January, the lower house of the Chilean congress passedresolution instructing the government to make it possible to issue compulsory licenses for prescription drugs. A few weeks later, several lawmakers asked Chilean health minister Carmen Castillo Taucher to issue compulsory licenses for the Xtandi prostate cancer therapy and several hepatitis C medicines sold by Gilead Sciences (GILD).

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy